Roth Capital Initiates Coverage on BUDA (NYSEAMERICAN:BUDA)

Equities researchers at Roth Capital began coverage on shares of BUDA (NYSEAMERICAN:BUDA) in a research report issued on Monday, MarketBeat.com reports. The firm set a “buy” rating and a $12.00 price target on the stock. Roth Capital’s target price suggests a potential upside of 52.09% from the stock’s current price.

BUDA Price Performance

BUDA opened at $7.89 on Monday. BUDA has a 12 month low of $6.25 and a 12 month high of $12.00. The business has a fifty day moving average price of $8.17 and a 200 day moving average price of $8.93.

BUDA (NYSEAMERICAN:BUDA) last posted its quarterly earnings results on Friday, August 14th. The company reported $0.04 earnings per share (EPS) for the quarter. The company had revenue of $4.51 million during the quarter.

BUDA Company Profile

Buda Juice, Inc (NYSE American: BUDA) is a beverage company focused on producing and selling organic, cold-pressed juice products. Its offerings are designed to provide convenient, ready-to-consume beverages made from fruit, vegetables and other plant-based ingredients.

The company’s product portfolio includes cold-pressed juice shots and related functional beverage products, with formulations intended to support wellness and everyday nutrition. Buda Juice products are marketed through retail, natural and specialty food channels, as well as other distribution outlets.

Buda Juice serves consumers seeking refrigerated, minimally processed and plant-based beverage options.